Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
Etoposide, intermediate-dose cytarabine and carboplatin (VAC): a combination therapy for the blastic phase of chronic myelogenous leukemiaE Montefusco, M C Petti, G Alimena, et al.
International Journal of Cancer|November 15, 1990
Interleukin-1 and interleukin-2 control granulocyte- and granulocyte-macrophage colony-stimulating factor gene expression and cell proliferation in cultured acute myeloblastic leukemiaF Cozzolino, M Torcia, S Bettoni, et al.
Acta Haematologica|December 9, 2000
Granulocytic sarcoma with breast and skin presentation: a report of a case successfully treated by local radiation and systemic chemotherapyM Breccia, M C Petti, G Fraternali-Orcioni, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|April 13, 1999
Plasma amino acid concentrations in patients with acute myelogenous leukemiaM Muscaritoli, L Conversano, M C Petti, et al.
Blood|August 15, 1996
AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot studyG Avvisati, F Lo Coco, D Diverio, et al.
Leukemia & Lymphoma|November 1, 1995
MEC (mitoxantrone, etoposide and intermediate dose cytarabine): an effective induction regimen for previously untreated acute non-lymphocytic leukemiaG Visani, M C Petti, A Cenacchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1984
Sequential combination of systemic high-dose ara-C and asparaginase for the treatment of central nervous system leukemia and lymphomaS Amadori, G Papa, G Avvisati, et al.
Haematologica|December 1, 2001
Spontaneous remission in adult patients with de novo myelodysplastic syndrome: a possible eventM C Petti, R Latagliata, M Breccia, et al.
American Journal of Hematology|June 13, 1998
Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemiaM Montillo, S Mirto, M C Petti, et al.
Leukemia & Lymphoma|February 1, 1993
Bisantrene in relapsed and refractory acute myelogenous leukemiaA Spadea, M C Petti, M A Aloespiriti, et al.
Pageof 11